NEWBRY

STO · Equity

Newbury Pharmaceuticals AB (publ)

SE Healthcare Drug Manufacturers - Specialty & Generic

Latest week: 29 May 2026
Close: 1.420000
Fair value: 2.979846
Expectation: Undecided 47.25%

Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending: 29 May 2026
Latest Close: 1.42
12-Week Change: 33.33%
Trend Signal: Inactive
Expectation: Undecided 47.25%
Signal Weeks: 0 of 12
Vs Trend Line: Above
Vs Fair Value: Below
Relative Strength: -32.31
Market Dynamics: 1.29

Over the latest 12 completed weeks ending 2026-05-29, NEWBRY rose 33.33%, moving from 1.06 to 1.42. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -32.31 and has improved across the 12-week window. Market Dynamics is 1.29 on the latest week. Expectation is undecided at 47.25%.